Intellia Therapeutics is featured in Cathie Wood's portfolio and has a high Wall Street price target. The company's leading candidates look somewhat promising, but one of them just hit a major setback ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and profits thanks to an important cancer drug. It's developing other products ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of ...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) shares have shown interesting movement recently, supported by a mix of strong revenue growth and improved net income figures. Investors are watching ...

Detailed price information for Equinox Gold Corp (EQX-A) from The Globe and Mail including charting and trades.

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Duopharma Biotech Berhad (KLSE:DPHARMA) as an investment opportunity by projecting its future cash ...

Bloom Energy (NYSE: BE) hit it out of the park in October, delivering on every metric that matters and forging a multibillion ...